Everolimus Tablet
Product Images NDC 51991-821

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 51991-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Breckenridge Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Everolimus 01)

FDA Label Image

Figure 4 (Everolimus 02)

FDA Label Image

Figure (Everolimus 03)

FDA Label Image

Figure (Everolimus 04)

FDA Label Image

Principal Display Panel (2.5 mg Blister Pack Carton)

FDA Label Image

Principal Display Panel (5 mg Blister Pack Carton)

FDA Label Image

Principal Display Panel (7.5 mg Blister Pack Carton)

FDA Label Image

Principal Display Panel (10 mg Blister Pack Carton)

This text describes the instructions and precautions to be taken while using Everolimus Tablets. The dosage and storage conditions are given. The manufacturer details and contact information are also provided. The drug should be stored in its original container and protected from light and moisture. Each tablet contains 25 mg of everolimus. The package contains 28 tablets. The website www.bpirx.com can be visited for more information. The NDC code for these tablets is 51991-821.28.*

FDA Label Image

Everolimus 09

This is a description of an oral medication that comes in a package containing 28 tablets. The drug is called Everolimus Tablets and each tablet contains 5mg of the active ingredient called Everolimus. The medication should be stored at a temperature between 15-30°C (59-86°F) and should be kept in its original container to protect it from light and moisture. The dosage information is not available in the given text. The drug is manufactured by Naico Pharma Limited and distributed by Breckenridge Pharmaceutical Inc. For more information, visit the website or call the provided number.*

FDA Label Image

Everolimus 10

This is a description of a medication called Everolimus in tablet form. The recommended dosage information is not provided, so it is advised to consult the package insert. The tablets should be stored at a temperature not exceeding 25°C and protected from moisture and light. The manufacturer is Natco Pharma Limited and it is distributed by Breckenridge Pharmaceutical, Inc. The medication should be kept out of the reach of children. The tablets are available in a package of 28 and each tablet contains 7.5mg of everolimus. For additional information, visit www.bpirc.com or call -1-800-367-3395.*

FDA Label Image

Everolimus 11

This is a medication called Everolimus, which comes in 28 tablets per carton. The dosage instructions and storage conditions are available on the package insert. The medicine should be kept in its original container and protected from light and moisture, at a temperature between 15-30°C (59-86°F). This medication is only for oral use and is sold by Natco Pharma Limited, India, and distributed by Breckenridge Pharmaceutica, Inc, CT. It can be harmful to children, so it must be kept out of their reach. For more information, visit the website mentioned on the package or call the number provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.